IKZF1 in acute lymphoblastic leukemia: the rise before the fall?

Abstract excerpt

Acute lymphoblastic leukemia (ALL) is the most common malignancy in children and adolescents and in recent decades, the survival rates have risen to >90% in children largely due the introduction of risk adapted therapy. Therefore, knowledge of factors influencing risk of relapse is important. The transcription factor IKAROS is a regulator of lymphocyte development and alterations of its coding gene, IKZF1, are...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to IKZF1 gene
• Share to Ikaros Transcription Factor
• Share to Mutation